# Venglustat PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/venglustat

> The PDUFA target action date for venglustat, sponsored by Sanofi (SNY), is November 25, 2026. Status: scheduled.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### When is the venglustat PDUFA date?

The PDUFA target action date for venglustat, sponsored by Sanofi (SNY), is November 25, 2026. Status: scheduled. Press release filed with the SEC (EX-99): "The target action date for the FDA decision is November 25, 2026." Last confirmed July 30, 2026. [Calendar and source filings](https://sec-api.dev/pdufa/venglustat)

Source: Press release filed with the SEC (EX-99), accession 0001121404-26-000008, https://www.sec.gov/Archives/edgar/data/1121404/000112140426000008/pressreleaseq22026english.htm (retrieved 2026-11-12). Last confirmed 2026-07-30. Cite: https://sec-api.dev/pdufa/venglustat#answer

## Key facts

| Field | Value |
| --- | --- |
| Drug | venglustat |
| Codes | GZ402671 |
| Sponsor | Sanofi (SNY) https://sec-api.dev/companies/sny/catalysts |
| Indications |  |
| Modality | small_molecule |
| FDA designations | breakthrough, orphan, priority review |

## Timeline

### November 25, 2026: PDUFA date

- Status: scheduled. Date confidence: exact.
- First seen 2026-06-08, last confirmed 2026-07-30.
- Press release filed with the SEC (EX-99) (accession 0001121404-26-000008): "The target action date for the FDA decision is November 25, 2026." https://www.sec.gov/Archives/edgar/data/1121404/000112140426000008/pressreleaseq22026english.htm
- Press release filed with the SEC (EX-99) (accession 0001628280-26-050803): "The target action date for the FDA decision is November 25, 2026." https://www.sec.gov/Archives/edgar/data/1121404/000162828026050803/exhibit992-2026halfyearman.htm
- Press release filed with the SEC (EX-99) (accession 0001193125-26-260613): "The target action date for the FDA decision is November 25, 2026." https://www.sec.gov/Archives/edgar/data/1121404/000119312526260613/d123884dex991.htm

Calendar months: [November 2026](https://sec-api.dev/fda-calendar/2026-11)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/venglustat.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "Venglustat PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/venglustat

```bibtex
@misc{secapidev_pdufa_venglustat_20261116,
  title        = {Venglustat PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/venglustat}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_venglustat_20261116","title":"Venglustat PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/venglustat","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
